The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis

Colorectal cancer (CRC) remains one of the top cancers in the world. Although early detection improves the survival rate to around 90%, late detection would mean the need to use chemotherapy or radiotherapy, especially if surgery is not feasible. 5-fluorouracil (5-FU) is one of the common anti-canc...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandra Arcilla Xin Hui Sim, Jia Ying Cheam, Jodi Woan-Fei Law, Vengadesh Letchumanan, Yatinesh Kumari, Satoshi Ogawa, Sunny Hei Wong, Kok-Gan Chan, Loh Teng-Hern Tan
Format: Article
Language:English
Published: HH Publisher 2023-07-01
Series:Progress in Microbes and Molecular Biology
Online Access:https://journals.hh-publisher.com/index.php/pmmb/article/view/827
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832541390716796928
author Alexandra Arcilla Xin Hui Sim
Jia Ying Cheam
Jodi Woan-Fei Law
Vengadesh Letchumanan
Yatinesh Kumari
Satoshi Ogawa
Sunny Hei Wong
Kok-Gan Chan
Loh Teng-Hern Tan
author_facet Alexandra Arcilla Xin Hui Sim
Jia Ying Cheam
Jodi Woan-Fei Law
Vengadesh Letchumanan
Yatinesh Kumari
Satoshi Ogawa
Sunny Hei Wong
Kok-Gan Chan
Loh Teng-Hern Tan
author_sort Alexandra Arcilla Xin Hui Sim
collection DOAJ
description Colorectal cancer (CRC) remains one of the top cancers in the world. Although early detection improves the survival rate to around 90%, late detection would mean the need to use chemotherapy or radiotherapy, especially if surgery is not feasible. 5-fluorouracil (5-FU) is one of the common anti-cancer drugs used in treating CRC. It is the drug that has the greatest efficacy on CRC. Although it improves the survival rate, it has many detrimental side effects. One of these side effects is intestinal mucositis. It is described as having reduced villus height, villus atrophy, crypt fissure, abdominal discomfort, diarrhoea, and weight loss. Clinically, there is no conclusive treatment therapy for mucositis. This is possibly due to the complex mechanism of the pathobiology of intestinal mucositis that includes the production of pro-inflammatory cytokines and increased epithelial cell apoptosis. 5-FU itself is known to cause gut dysbiosis. Current studies revealed probiotics play a role in attenuating this inflammatory process of intestinal mucositis by reversing gut dysbiosis, reducing the expression of pro-inflammatory cytokines, and reducing intestinal damage. This review outlines the latest evidence supporting probiotic use in ameliorating 5-FU induced intestinal mucositis, thereby promoting good health and well-being in colorectal cancer patients receiving 5-FU chemotherapy.
format Article
id doaj-art-2145dad5bcbc4f5e91aa6c69d0e8046b
institution Kabale University
issn 2637-1049
language English
publishDate 2023-07-01
publisher HH Publisher
record_format Article
series Progress in Microbes and Molecular Biology
spelling doaj-art-2145dad5bcbc4f5e91aa6c69d0e8046b2025-02-04T08:39:51ZengHH PublisherProgress in Microbes and Molecular Biology2637-10492023-07-016110.36877/pmmb.a0000339The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal MucositisAlexandra Arcilla Xin Hui SimJia Ying CheamJodi Woan-Fei LawVengadesh LetchumananYatinesh KumariSatoshi OgawaSunny Hei WongKok-Gan ChanLoh Teng-Hern Tan Colorectal cancer (CRC) remains one of the top cancers in the world. Although early detection improves the survival rate to around 90%, late detection would mean the need to use chemotherapy or radiotherapy, especially if surgery is not feasible. 5-fluorouracil (5-FU) is one of the common anti-cancer drugs used in treating CRC. It is the drug that has the greatest efficacy on CRC. Although it improves the survival rate, it has many detrimental side effects. One of these side effects is intestinal mucositis. It is described as having reduced villus height, villus atrophy, crypt fissure, abdominal discomfort, diarrhoea, and weight loss. Clinically, there is no conclusive treatment therapy for mucositis. This is possibly due to the complex mechanism of the pathobiology of intestinal mucositis that includes the production of pro-inflammatory cytokines and increased epithelial cell apoptosis. 5-FU itself is known to cause gut dysbiosis. Current studies revealed probiotics play a role in attenuating this inflammatory process of intestinal mucositis by reversing gut dysbiosis, reducing the expression of pro-inflammatory cytokines, and reducing intestinal damage. This review outlines the latest evidence supporting probiotic use in ameliorating 5-FU induced intestinal mucositis, thereby promoting good health and well-being in colorectal cancer patients receiving 5-FU chemotherapy. https://journals.hh-publisher.com/index.php/pmmb/article/view/827
spellingShingle Alexandra Arcilla Xin Hui Sim
Jia Ying Cheam
Jodi Woan-Fei Law
Vengadesh Letchumanan
Yatinesh Kumari
Satoshi Ogawa
Sunny Hei Wong
Kok-Gan Chan
Loh Teng-Hern Tan
The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
Progress in Microbes and Molecular Biology
title The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
title_full The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
title_fullStr The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
title_full_unstemmed The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
title_short The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
title_sort ameliorative role of probiotics in 5 fluorouracil induced intestinal mucositis
url https://journals.hh-publisher.com/index.php/pmmb/article/view/827
work_keys_str_mv AT alexandraarcillaxinhuisim theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT jiayingcheam theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT jodiwoanfeilaw theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT vengadeshletchumanan theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT yatineshkumari theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT satoshiogawa theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT sunnyheiwong theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT kokganchan theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT lohtengherntan theameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT alexandraarcillaxinhuisim ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT jiayingcheam ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT jodiwoanfeilaw ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT vengadeshletchumanan ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT yatineshkumari ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT satoshiogawa ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT sunnyheiwong ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT kokganchan ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis
AT lohtengherntan ameliorativeroleofprobioticsin5fluorouracilinducedintestinalmucositis